SYSTEMIC PROTEOMIC PROFILES OF COPD PATIENTS AT CLINICAL STABILITY AND EXACERBATION
C. Enriquez-Rodríguez (Barcelona, Spain), C. Casadevall (Barcelona, Spain), S. Pascual-Guardia (Barcelona, Spain), R. Faner (Barcelona, Spain), G. Peces-Barba (Madrid, Spain), J. López-Campos (Sevilla, Spain), E. Monsó (Barcelona, Spain), A. Agustí (Barcelona, Spain), J. Gea Guiral (Barcelona, Spain)
Source: International Congress 2022 – Exacerbations in COPD: biomarkers and management
Session: Exacerbations in COPD: biomarkers and management
Session type: Thematic Poster
Number: 196
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
C. Enriquez-Rodríguez (Barcelona, Spain), C. Casadevall (Barcelona, Spain), S. Pascual-Guardia (Barcelona, Spain), R. Faner (Barcelona, Spain), G. Peces-Barba (Madrid, Spain), J. López-Campos (Sevilla, Spain), E. Monsó (Barcelona, Spain), A. Agustí (Barcelona, Spain), J. Gea Guiral (Barcelona, Spain). SYSTEMIC PROTEOMIC PROFILES OF COPD PATIENTS AT CLINICAL STABILITY AND EXACERBATION. 196
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|